Krónikus vesebetegség: vizsgálatok itt: Szlovákia
8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Kosice, Myjava, Nitra, Presov, Púchov, Trenčín, Trnava, Žilina
- Életkor
- 18 év and over
- People
- 5000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - 3. fázisTaking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Bratislava, Galanta, Ilava, Petrzalka, Pezinok, Poprad, Stará Turá, Trenčín, Trstena, Zilina, Žilina
- Életkor
- 50 év and over
- People
- 7140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - 3. fázisTaking peopleA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Košice
- Életkor
- 18 év to 100 év
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - 2/3. fázisTaking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Levice, Lučenec, Púchov
- Életkor
- 18 év and over
- People
- 3110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - 3. fázisTaking peopleEfepoetin alfa for treatment of anemia in chronic kidney disease on dialysis
- Where
- Bratislava, Galanta, Pezinok, Púchov, Sala, Zvolen
- Életkor
- 18 év and over
- People
- 337 worldwide
- Run by
- Genexine Inc.
See details and how to join2023-503634-50-01 · EU 2023-503634-50-01 - Korai 1. fázisCsak meghívásosThe MIMIGA Study is a Randomized, Double-blind, Placebo-controlled Crossover Trial Evaluating the Safety and Efficacy of SCFA vs. Placebo. Administered Orally Once Daily With Standard Care, it Aims to Prevent CKD Progression in Biopsy-proven IgA Nephropathy by Modulating the Gut Microbiome.
- Where
- Martin
- Életkor
- 18 év and over
- People
- 120
- Run by
- University Hospital, Martin
See details and how to joinNCT07750249 - No phaseTaking peoplePhysical Performance Assessment in Kidney Transplant Evaluation
- Where
- Martin
- Életkor
- 18 év and over
- People
- 50
- Run by
- University Hospital, Martin
See details and how to joinNCT07338929 - 3. fázisCsak meghívásosSilymarin's Advantage on Graft Effectiveness
- Where
- Martin
- People
- 130
- Run by
- University Hospital, Martin
See details and how to joinNCT06801886